Eaton Vance Management Astrazeneca PLC Transaction History

Eaton Vance Management

$67.5 Billion
Q3 2022

A detailed history of Eaton Vance Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Eaton Vance Management holds 1,462,963 shares of AZN stock, worth $114 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,462,963

Previous 1,463,195 0.02%

Holding current value

$114 Million

Previous $96.7 Million 17.01%

% of portfolio

0.12%

Previous 0.14%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $12,300 - $31,494	-232 Reduced 0.02%	1,462,963 $80.2 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $585,488 - $702,863	-9,880 Reduced 0.67%	1,463,195 $96.7 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $68,758 - $82,826	1,234 Added 0.08%	1,473,075 $97.7 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $1.56 Million - $1.84 Million	28,853 Added 2.0%	1,471,841 $85.2 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $67.2 Million - $73.6 Million	1,210,286 Added 520.1%	1,442,988 $86 Million

Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $304,949 - $379,013	-6,298 Reduced 2.64%	232,702 $13.9 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $21,552 - $24,879	457 Added 0.19%	239,000 $11.9 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $185,831 - $222,216	3,830 Added 1.63%	238,543 $11.9 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $63,896 - $73,564	-1,204 Reduced 0.51%	234,713 $12.9 Million
Q2 2020 Nov 20, 2020	SELL	$43.1 - $55.31 $22,843 - $29,314	-530 Reduced 0.22%	235,917 $12.5 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $7.84 Million - $10.1 Million	-181,974 Reduced 43.49%	236,447 $12.5 Million
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $12.4 Million - $16.9 Million	-328,683 Reduced 43.99%	418,421 $18.7 Million
Q4 2019 Feb 11, 2020	SELL	$42.46 - $50.46 $1.03 Million - $1.23 Million	-24,310 Reduced 3.15%	747,104 $37.3 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $8.35 Million - $9.46 Million	208,094 Added 36.94%	771,414 $34.4 Million
Q2 2019 Nov 21, 2019	BUY	$37.28 - $41.68 $19,758 - $22,090	530 Added 0.09%	563,320 $23.3 Million
Q2 2019 Aug 16, 2019	BUY	$37.28 - $41.68 $4.81 Million - $5.38 Million	129,033 Added 29.75%	562,790 $23.2 Million
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $15.4 Million - $18.7 Million	433,757 New	433,757 $17.5 Million

Others Institutions Holding AZN

# of Institutions

1,246

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Account

Eaton Vance Management Astrazeneca PLC Transaction History